Formoterol Fumarate Inhalation Solution — Class II drug recall D-0073-2027
Ongoing recall by The Ritedose Corporation, reported 2026-11-04, distributed nationwide. Failed Impurities/Degradation Specification
| Recall number | D-0073-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | The Ritedose Corporation, Columbia, SC, United States |
| Recall initiated | 2026-10-15 |
| Classified | 2026-10-23 |
| Reported by FDA | 2026-11-04 |
| Distributed | Nationwide (US) |
| Quantity | 3,210 cartons |
| Reason classes | specification failure |
| NDC | 76204-0030, 76204-0030-01, 76204-0030-02 |
| Lot numbers | 25BL0 |
| Expiration dates | 2027-02-28 |
Product
Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC
Reason for recall
Failed Impurities/Degradation Specification
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0073-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.